Acid evoked thermal hyperalgesia involves peripheral P2Y1 receptor mediated TRPV1 phosphorylation in a rodent model of thrombus induced ischemic pain
© Kwon et al.; licensee BioMed Central Ltd. 2014
Received: 4 June 2013
Accepted: 30 December 2013
Published: 9 January 2014
We previously developed a thrombus-induced ischemic pain (TIIP) animal model, which was characterized by chronic bilateral mechanical allodynia without thermal hyperalgesia (TH). On the other hand we had shown that intraplantar injection of acidic saline facilitated ATP-induced pain, which did result in the induction of TH in normal rats. Because acidic pH and increased ATP are closely associated with ischemic conditions, this study is designed to: (1) examine whether acidic saline injection into the hind paw causes the development of TH in TIIP, but not control, animals; and (2) determine which peripheral mechanisms are involved in the development of this TH.
Repeated intraplantar injection of pH 4.0 saline, but not pH 5.5 and 7.0 saline, for 3 days following TIIP surgery resulted in the development of TH. After pH 4.0 saline injections, protein levels of hypoxia inducible factor-1α (HIF-1α) and carbonic anhydrase II (CA II) were elevated in the plantar muscle indicating that acidic stimulation intensified ischemic insults with decreased tissue acidity. At the same time point, there were no changes in the expression of TRPV1 in hind paw skin, whereas a significant increase in TRPV1 phosphorylation (pTRPV1) was shown in acidic saline (pH 4.0) injected TIIP (AS-TIIP) animals. Moreover, intraplantar injection of chelerythrine (a PKC inhibitor) and AMG9810 (a TRPV1 antagonist) effectively alleviated the established TH. In order to investigate which proton- or ATP-sensing receptors contributed to the development of TH, amiloride (an ASICs blocker), AMG9810, TNP-ATP (a P2Xs antagonist) or MRS2179 (a P2Y1 antagonist) were pre-injected before the pH 4.0 saline. Only MRS2179 significantly prevented the induction of TH, and the increased pTRPV1 ratio was also blocked in MRS2179 injected animals.
Collectively these data show that maintenance of an acidic environment in the ischemic hind paw of TIIP rats results in the phosphorylation of TRPV1 receptors via a PKC-dependent pathway, which leads to the development of TH mimicking what occurs in chronic ischemic patients with severe acidosis. More importantly, peripheral P2Y1 receptors play a pivotal role in this process, suggesting a novel peripheral mechanism underlying the development of TH in these patients.
During pathological conditions such as ischemia, inflammation and tissue injury, a huge array of endogenous chemicals are released into the tissue that contribute to sensory phenomena including pain and hyperalgesia. These endogenous pain producing and sensitizing substances activate nociceptive nerve endings by binding to receptor molecules on their surface. Increasing evidence indicates that different sets of molecules contribute to mechanical and thermal hypersensitivity via several mechanisms in peripheral tissue [1–4]. A representative molecule is TRPV1, which is a noxious heat stimulus sensor and its activation results in a decreased threshold for heat stimuli [5–7]. It is well recognized that activation of TRPV1 receptors by various pro-algesic substances such as protons, ATP, bradykinin and prostaglandins contribute to peripheral sensitization, particularly to heat stimuli during the pathological states [1, 5].
Ischemic pain typically results from a shortage of blood supply to tissue and is associated with a number of pathological states including atherosclerosis and intermittent claudication resulting from peripheral arterial disease (PAD) [8, 9]. Intermittent claudication is a type of muscle pain which occurs during ambulation, and this is an early symptom in PAD patients . As the disease progresses, severe limb ischemia might result in pain at rest without exercise . Although patients with PAD demonstrate a range of ischemic pain severity, with abnormal response to mechanical and heat stimulus [9, 11, 12], mechanistic differences in pain intensity and modality have been poorly explored. Since there were no proper animal models that mimic the mechanisms of peripheral ischemia observed in PAD patients, we previously developed and described a new animal model of thrombus-induced ischemic pain (TIIP) in the rat and investigated the peripheral mechanisms underlying this ischemia induced pain [13, 14]. TIIP rats showed persistent bilateral mechanical allodynia and we demonstrated that peripheral acid-sensing ion channels (ASICs) and P2X receptors were involved in the maintenance of this thrombus-induced ischemic pain . These results indicated that protons associated with low ischemic pH and an increased concentration of ATP at the ischemic site played crucial roles in the development of ischemia-induced peripheral sensitization.
Thermal hyperalgesia (TH) has been shown to develop in chronic ischemic patients with severe acidosis and thus we would anticipate that it should be present in the TIIP model. While ischemia-induced conditions are closely associated with TRPV1 activation [15–19], and TRPV1 is the endpoint target of a variety of sensitizing substances including protons and ATP [1, 5, 6], TIIP rats show no hypersensitivity to heat stimuli, i.e. thermal hyperalgesia (TH), and changes in the pharmacological activity of peripheral TRPV1 is not detected in this model [13, 14]. These findings suggest that the lack of TH development in TIIP animals might be caused by the internal ischemic environment, such that the acidity and the ATP concentration are inadequate to activate TRPV1. Previously, we have demonstrated a facilitatory effect of acidic pH on ATP-induced hypersensitivity in the normal rat’s hind paw utilizing α,βme-ATP as a substitute for endogenous ATP . Although injection of acidic pH or α,βme-ATP alone failed to activate TRPV1 and P2Y1 receptors and produce TH, a combination of acidic pH in the presence of α,βme-ATP, did induce a transient TH via the activation of peripheral P2Y1 and TRPV1 receptors ; these results suggested that the synergistic action of acidic pH and ATP directly or indirectly activated TRPV1 and P2Y1 receptors. However, the interrelationship between these receptors and the potential molecular mechanisms underlying the development of TH under ischemic conditions is unclear. In the present study we used the TIIP animal model to investigate the peripheral induction mechanisms of TH shown in chronic ischemic patients with severe acidosis. In this regard, the present study examines: (1) whether injection of acidic saline into the hind paw causes the development of TH and changes the local tissue ischemic and acidic conditions in TIIP rats; (2) which proton and ATP sensing receptors are involved in this newly developed TH; and finally (3) whether there are functional interactions among these TH related receptors.
Materials and methods
Sprague–Dawley rats (weighing 350 to 400 g) were obtained from the Laboratory Animal Center of Seoul National University (SNU). All experimental procedures were approved by the SNU Animal care and Use Committee and performed according to guidelines established by NIH (NIH Revised Guide for the Care and Use of Laboratory Animals; eighth edition, National Academies Press, 2011). Animals were housed in a standard animal facility maintained in a 12 h light/dark cycle and a constant room temperature (maintained between 20–25°C) with 40–60% humidity. Food and water were available ad libitum throughout the investigation.
TIIP surgery was performed according to the method described by Seo et al. . Briefly, rats were first anesthetized intraperitoneally with a Zoletil 50® (Virbac laboratories, 06516 Carros) and Rompun® (Bayer Korea Ltd, Ansan) mixture (combining 2.5 mg of Zoletil 50® with 0.47 mg of Rompun® in saline), and then a small incision was made in the femoral triangle of the left hindlimb. The femoral artery was separated from the femoral vein and nerve by a piece of moisture-resistant film (Parafilm®, Chicago, IL, USA, 1 × 2.5 cm) to prevent possible ferrous chloride damage to these structures. A filter paper disc (0.5 × 0.5 cm; No. 2, Toyo Roshi Kaisha, Ltd., Japan) soaked with 20% FeCl2 (FeCl2 · 4H2O, Sigma, St. Louis, MO, USA) solution was placed on the femoral artery for 20 minutes. After the incision was surgically closed and covered by surgical dressing, animals were kept in a warming chamber (28°C) until they completely recovered from the anesthesia.
Intraplantar drug administration and experimental procedures
AMG9810 (a TRPV1 antagonist), chelerythrine (a PKC inhibitor), Amiloride (an ASICs blocker), TNP-ATP (a P2X receptor antagonist), or MRS2179 (a P2Y1 receptor antagonist) was injected into the hind paw in order to investigate the mechanisms underlying the development of thermal hyperalgesia (TH). The potential involvement of TRPV1 and PKC dependent pathways during the maintenance phase of TH was evaluated by a single injection of AMG9810 and chelerythrine at day 3 post-surgery. To further explore the intrinsic mechanisms underlying the development of TH, Amiloride, AMG9810, TNP-ATP and/or MRS2179 were repeatedly injected once a day (D0-D3 after surgery) 30 min before the acidic saline injection. Each control group received an intraplantar injection of the appropriate vehicle for each drug. Animals were randomly assigned to experimental groups and subsequent drug treatment and behavioral analyses were performed blindly.
Assessment of thermal hyperalgesia
To assess nociceptive responses to noxious heat stimuli, we measured the paw withdrawal response latency (PWL) using a plantar test apparatus (Series 8, Model 390, IITC Life Science Inc., Woodland Hills, CA, USA), and evaluated animal’s sensitivity to noxious heat stimulation (thermal hyperalgesia). Before the test, rats were placed in a plastic chamber with a glass floor and allowed to acclimate for 15 minutes. Room temperature was constantly maintained between 26–28°C. A radiant heat source was positioned under the glass floor beneath the hind paw to be tested and withdrawal latency was measured by using a photoelectric cell connected to a digital clock. Baseline latency responses (10–15 sec) were determined before experimental treatment. The test was repeated in each hind paw at each time point and the mean withdrawal latency was calculated. A cut-off time of 20 seconds was used to protect the animal from excessive tissue damage.
In order to examine the possible role of TRPV1 containing peripheral nerve fibers, we treated the animals with the potent capsaicin analog, Resiniferatoxin (RTX, 0.3 mg/kg; Sigma, St. Louis, MO) dissolved in a mixture of 10% Tween 80, 10% ethanol, 80% normal saline . After rats were anesthetized with 3% isoflurane in a mixture of N2O/O2 gas, either RTX or vehicle was injected subcutaneously in a volume of 0.2 ml into the scruff of the neck. The eye wipe reflex test was subsequently performed to check whether RTX treatment destroyed capsaicin sensitive primary afferent fibers at day 2 post-RTX injection. A diluted capsaicin solution (0.01%, dissolved in saline) was dropped onto cornea, and then the number and the duration of eye wipes were counted for 1 min. Following the eye wipe reflex test, we performed sham and TIIP surgery in vehicle-treated animals and in RTX-treated animals that showed no response to diluted capsaicin solution.
Western blot analysis
Plantar muscle and skin from the ipsilateral hind paw were collected from anesthetized rats at postoperative day 3; to avoid acute effects of adjusted saline injection, we obtain tissue samples for western blot analysis at least 2 hours after saline injections. The tissue were homogenized in buffer containing 1 M Tris (pH 7.5), 1% NP-40, 0.5 M EDTA (pH 7.5), 50 mM EGTA, 1 M dithiothreitol, 1 M benzanidine and 0.1 M PMSF. The total amount of protein in each sample was determined using the Bradford dye assay prior to loading on polyacrylamide gels. The tissue homogenates (30 μg protein) were separated by 10% SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose. After the blots had been washed with TBST [10 mM Tris–HCl (pH 7.6), 150 mM NaCl, 0.05% Tween-20], the membranes were blocked with 5% skim milk for 1 hour. The muscle samples were incubated with primary antibodies for hypoxia inducible factor-1α (HIF-1α, 1:1000) or carbonic anhydrase II (CA II, 1:1000), which were purchased from the Santa Cruz Biotechnology (Delaware, CA). We utilized a TRPV1 polyclonal antibody (1:1000, Santa Cruz Biotechnology Inc., Santa Cruz, California, USA) and a pTRPV1 (phosphor S800) polyclonal antibody (1:1000, Abnova corporation, Taipei City, Taiwan) for skin samples. β-actin antibody was used as a loading control (Sigma, St. Louis, MO). After the secondary antibody reaction, the bands were visualized with enhanced chemiluminescence (Amersham Pharmacia Biotech, England, UK). The positive pixel area of specific bands was measured with a computer-assisted image analysis system (Metamorph®, version 6.3r2, Molecular Devices Corporation, PA) and normalized against the corresponding β-actin loading control bands. Then the ratio of pTRPV1 /TRPV1 expression was calculated. The mean values of the TRPV1 and pTRPV1/TRPV1 positive pixel area in the sham group was set at 100% and used for comparison with the experimental group.
Animals were deeply anesthetized with an intra-peritoneal injection of a Zoletil-Rompun-saline mixture (2:1:2). Animals were perfused transcardially with calcium-free Tyrode’s solution, followed by a fixative containing 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The ipsilateral DRGs (L4-L5) were collected after perfusion, post-fixed in the identical fixative for 4 hours and then placed in 30% sucrose in PBS (pH 7.4) at 4°C overnight. Frozen serial frontal sections (10 μm) were cut through the DRG L4–L5 using a cryostat (Microm, Walldorf, Germany). These serial sections were pre-blocked with 3% normal donkey serum and 0.3% Triton X-100 in PBS for 1 hour at room temperature. Tissue sections were incubated at 4°C with goat polyclonal TRPV1 antibody (1:250, Santa Cruz Biotechnology Inc., Santa Cruz, California, USA) for 48 h and followed by AlexaFluor 488 conjugated secondary antibody (1:500, invitrogen, Carlsbad, California, USA) for 2 hr at room temperature.
3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide hydrochloride (Amiloride), (2E)-N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-3-[4-(1,1-dimethylethyl)phenyl]-2-propenamide (AMG9810), Chelerythrine, 2′,3′–O–(2,4,6-Trinitrophenyl)adenosine-5′-triphosphate triethylammonium salt (TNP-ATP), 2′-Deoxy-N6-methyladenosine 3′,5′-bisphosphate tetrasodium salt (MRS2179) and [[(1R,2R,3S,4R,5S)-4-[6-Amino-2-(methylthio)-9H-purin-9-yl]-2,3-dihydroxybicyclo[3.1.0]hex-1-yl]methyl] diphosphoric acid mono ester trisodium salt (MRS2365) were purchased from Tocris (Ellisville, MO, USA). Amiloride, TNP-ATP, MRS2179 were dissolved in saline, respectively. AMG9810 was dissolved in 10% ethyl alcohol. Chelerythrine was dissolved in 5% DMSO. A 30 μl volume of one of the above drugs was injected intraplantarly for individual experiments.
Statistical analysis was performed using Prism 5.1 (GraphPad Software, San Diego, CA). One-way analysis of variance (ANOVA) was performed to determine the change in TRPV1 and pTRPV1/TRPV1 concentrations in the ischemic hind paw skin. For posthoc analysis, the Newman-Keuls multiple comparison test was subsequently performed to determine significant differences among groups. A value of P < 0.05 was considered to be statistically significant. Behavioral data were tested using a two-way ANOVA to determine the overall effect of the drugs in each time-course.
Long-term effects of intraplantar acidic saline injection on thermal hyperalgesia (TH) in TIIP rats
We injected pH adjusted saline solution (pH 4.0, 5.5, or 7.0) into the hind paw of TIIP rats once per day from days 0 to 3 after TIIP surgery to determine the potential effect of a more acidic, ischemic environment on thermal nociception. Repeated injection of pH 4.0 saline (Days 0 to 3 after surgery) caused a significant reduction in paw withdrawal latency to thermal stimuli in TIIP rats (Figure 1A). In order to investigate long-term effects of acid induced changes in heat hypersensitivity, we measured TH at day 1, 2, 3, 5, 7 and 12 after the surgery. The threshold for heat stimulation was evaluated at 2 hours post-injection in order to avoid potential acute effects of the pH 4.0 saline solution. TH developed on day 1 post-injection following TIIP surgery and was maintained throughout the entire 3-day injection period (Figure 1A; **P < 0.01, ***P < 0.005 vs sham + pH 7.0 saline), and gradually recovered over a period of several days after the injection period ended (Figure 1A). By contrast, the thermal threshold was unchanged in TIIP rats injected intraplantarly with pH 7.0 saline in the ipsilateral paw and thus, TH never developed. Importantly the two control groups (sham rats injected daily with pH 4.0 or pH 7.0 saline solutions) did not develop TH (Figure 1A) indicating that the ischemic condition was necessary for this acidic-induced TH to develop. Furthermore, one group of TIIP rats was injected into the ischemic hind paw with pH 5.5 saline on 3 consecutive days, but the injection of the pH 5.5 saline solution did not significantly decrease the threshold for the thermal stimulus (Figure 1A). Since only pH 4.0 saline induced the behavioral changes in thermal hypersensitivity in TIIP rats, we injected pH 4.0 saline into the ischemic hind paw in the remaining experiments as outlined below.
Short-term effects of intraplantar acidic saline injection on thermal hyperalgesia (TH) in TIIP rats
In addition to the long-term changes in acid induced TH in TIIP rats, we observed changes in the time course of behavioral responses induced by a single injection of acidic saline (at days 1 and 3 post-surgery). After pH 4.0 injection, we observed changes in the withdrawal response latency (sec) at 30 min, 1, 2, 4, 8 and 12 hours post-injection (Figure 1B, 1C). On day 1, TIIP rats showed no significant TH prior to pH 4.0 injection compared to sham + pH 4.0 rats (Figure 1B). Following pH 4.0 saline injections, TIIP rats developed a significant TH compared to sham rats; TH was observed from 30 min to 8 hours post-injection. This thermal hyperalgesia slowly decreased beginning at 8 hours post-injection and the animals showed normal thermal responses by 12 hours after injection (Figure 1B; *P < 0.05, **P < 0.01 and ***P < 0.005 vs sham + pH 4.0 saline). At day 3 post-surgery, significant TH was already present in acidic saline injected TIIP (AS-TIIP) rats before pH 4.0 saline injection (Figure 1C; **P < 0.01 vs sham + pH 4.0 saline). Moreover, after pH 4.0 injections, AS-TIIP rats showed persistent TH and did not recover until 12 hours post-injection (Figure 1C; **P < 0.01 and ***P < 0.005 vs sham + pH 4.0 saline). Collectively, the TH induced by a single acidic saline injection was transient at day 1; however, following 2 more acidic saline injections, the TIIP rats developed persistent thermal hypersensitivity which was maintained for 2 days following the cessation of acidic saline injection (until day 5 post-surgery).
Injection of acidic saline results in an increase in hypoxic status and acidity of the ischemic hind paw
TRPV1 and phosphorylated TRPV1 expression of hind paw lysates in acidic saline injected TIIP (AS-TIIP) rats
TRPV1 and phosphorylated TRPV1 expression of hind paw lysates in acidic saline injected TIIP (AS-TIIP) rats with resiniferatoxin (RTX) treatment
The involvement of TRPV1 and PKC dependent pathways in the maintenance of thermal hyperalgeisa (TH) in acidic saline injected TIIP (AS-TIIP) rats
The involvement of proton sensing ion channels and P2 receptors in the induction of thermal hyperalgesia (TH) in acidic saline injected TIIP (AS-TIIP) rats
Peripheral P2Y1 receptors modulate TRPV1 activity by PKC-dependent phosphorylation in acidic saline injected TIIP (AS-TIIP) rats
It has been reported that tissue acidity corresponds to the severity of hypoxic status, and the tissue acidic environment is a major factor for triggering ischemia related pathological consequences [23, 34, 35]. In terms of pain hypersensitivity, although low tissue pH at the ischemic site has been considered a crucial factor in the development of ischemic pain [8, 14, 36], the contribution of the acidic environment to ischemia-induced thermal hypersensitivity has not been delineated. The present study is the first to demonstrate that under peripheral ischemic conditions an increase in tissue acidity results in the development of thermal hyperalgesia (TH). Here, we injected pH 4.0 saline into the ischemic hind paw to evaluate how an acidic tissue environment affected both thermal hypersensitivity and TRPV1 activity under peripheral ischemic condition. Since hypoxia inducible factor-1α (HIF-1α) is a well-known indicator of hypoxia and carbonic anhydrase II (CA II) has been reported to be a major indicator of pH imbalance [23–29], we examine changes in these two factors in order to evaluate the degree of hypoxic injury and tissue acidity. We observed that repetitive acidic saline injection into the ischemic hind paw increased protein levels of both hypoxia inducible factor-1α (HIF-1a) and carbonic anhydrase II (CA II) in hind paw muscle (Figure 2). These results indicated that the presence of an acidic tissue environment intensified the ischemia-associated insults to the hind paw muscle tissue. Therefore, we postulate that injection of acidic saline into TIIP (AS-TIIP) rats represents a model of the ischemic condition with severe tissue acidosis.
Since the injection of pH 4.0 saline solution itself in sham rats did not affect thermal nociception (Figure 1), these findings indicated that an increased acidic environment in the presence of other pro-algesic substances under ischemic conditions could lead to the development of TH. It has been reported that there is a synergism between low tissue pH conditions and pro-algesic substances in their effect on nociceptor excitation [37, 38]. In the skin-nerve preparation, a strong interaction between acidic pH and inflammatory mediators resulted in an increased prevalence and magnitude of nociceptor excitation . This interaction was also shown in experimental tissue acidosis in human skin; e.g. the injection of additional inflammatory mediators into the acidic skin caused a more significant painful response . In a previous study we demonstrated that the synergism between acidic saline and ATP produced a significant facilitation of nociception (mechanical allodynia and thermal hypersensitivity) in the normal rat hind paw . Accordingly, it is reasonable to hypothesize that ATP may be one of the synergic factors that contribute to acidic pH-mediated pain development under ischemic conditions. Although we do not measure the exact concentration of tissue ATP in TIIP rats in the present study, it is well known that injured tissues possess a high concentration of extracellular ATP especially during early induction phase [39, 40]. In TIIP rats, intraplantar injection of a P2 antagonist effectively alleviated mechanical allodynia at day 3 after surgery . Moreover, in the current study, we injected acidic saline to the ischemic hind paw during this induction phase (D0 to D3), and observed increased thermal hypersensitivity. These results imply that during the early induction phase in which extracellular ATP concentration is elevated, injection of acidic saline could effectively modulate P2Y1 receptors, which could contribute to the development of increased thermal hypersensitivity.
Since previous studies have shown that P2Y1 and TRPV1 receptors are located in the same population of DRG neurons, we have examined the potential role of TRPV1 receptors in this process by examining the effect of injection of the specific TRPV1 antagonist AMG9810, using two different approaches. First, in order to investigate the potential involvement of TRPV1 in maintaining TH, we performed a single intraplantar injection of the selective TRPV1 antagoinst, AMG9810 at day 3. This injection resulted in short-term alleviation of the established TH (Figure 5A). Second, we performed repetitive intraplantar injection to further explore whether each acidic stimulation directly affected TRPV1 or not. AMG9810 were injected once a day (D0-D3 after surgery) 30 min before the acidic saline injection. Interestingly, this pre-blockade of TRPV1 before acidic saline failed prevent the induction of TH (Figure 6B). These results implied that TRPV1 was a final gate for acid induced TH in TIIP rats, but acid stimulation did not directly activate this channel.
In the current study, we discovered that peripheral P2Y1 receptors played a crucial role in acid induced TH, based on the fact that repeated pre-injection of MRS2179, a selective P2Y1 antagonist, effectively prevented the acidic saline-induced TH in AS-TIIP rats (Figure 6D). These results indicate that the acidic environment created by pH 4.0 saline injection in the ischemic hind paw modulates P2Y1 receptors, which in turn contribute to the development of TH. On the other hand, TRPV1 receptors do not appear to play a crucial role in the onset of TH in this model. In addition, we also concluded that ASICs did not contribute to thermal hypersensitivity in AS-TIIP rats (Figure 6A). Previously, we reported that peripheral ASICs were involved in maintaining ischemia-induced mechanical allodynia in TIIP . However, we were unable to investigate their contribution to TH in the present study, since TIIP rats have normal heat sensitivity. In the current study, we observed that low tissue pH in conjunction with ischemia resulted in the development of TH in TIIP rats, and ASICs were not involved in this ischemic thermal hypersensitivity. On the other hand, ASICs did contribute to mechanical allodynia in AS-TIIP rats (data not shown). These results suggest that ASICs are a modality specific contributor to mechanical allodynia in acid-induced nociception, and there are several reports supporting the specific role of ASICs in mechanical sensing and hypersensitivity [20, 41, 42].
Although pH 4.0 is quite an extreme pH not often seen even in pathophysiological conditions, several studies have examined the actual pH level in the plantar tissue, and they demonstrated that the measured tissue pH is considerably higher than solution pH level before injection [21, 41]. For example, Sluka et al. reported that the repeated injection of pH 4.0 saline into gastrocnemius muscle lowered the muscle pH averaged 6.5 with decreases in individual animals to pH 6 . Therefore, we have assumed that a single injection of pH 4.0 saline would not extremely decrease the tissue pH, and further considered that temporary acidic pH tissue condition induced by pH 4.0 saline could mimic the pathophysiological state shown in peripheral ischemic condition. Collectively, the acidic environment is easily buffered by physiological buffering systems [15, 21, 43], it may be difficult to activate TRPV1 receptors directly, since they only respond under relatively low tissue pH (pH < 5–6) [44–46]. Therefore, there is the strong possibility that the interaction of the acidic environment and ATP indirectly activate TRPV1 via P2Y1 receptors which up-regulates intracellular signaling cascades, but this only occurs in an ischemic environment in which tissue acidosis is present.
It is well recognized that activation of TRPV1 receptors contributes to peripheral sensitization, particularly to heat stimuli. Pro-algesic substances such as protons, ATP, bradykinin and prostaglandins sensitize nociceptors either by directly modulating the sensitivity of membrane receptors or by up-regulating intracellular signaling cascades . These signaling cascades include calcium dependent protein kinase (PKC), cyclic AMP-dependent protein kinase (PKA), and calcium-calmodulin dependent protein kinase (CaMKII) dependent phosphorylation . Since PKC dependent modulation of TRPV1 had been reported to be the main pathway stimulated by inflammatory mediators [5, 47, 48], an analysis of phosphorylated TRPV1 that targeted S800 was performed in the present study. Sham (pH 7.0 and 4.0), TIIP and AS-TIIP rats did not show any alterations in TRPV1 expression (Figure 3A), whereas the ratio of pTRPV1/TRPV1 was significantly elevated in AS-TIIP rats (Figure 3B). Although it has been reported that PKC dependent TRPV1 phosphorylation is critical in the TRPV1 response to its agonist in vitro [7, 49, 50], this is the first evidence that increased phosphorylation of TRPV1 in peripheral tissues directly correlates with behavioral changes in vivo. Since TRPV1 is not only located in peripheral nerve fibers, but also in the keratinocytes distributed in the epidermis of the skin, our initial western blot data contain TRPV1 from both neuronal and non-neuronal origins. Therefore, in attempt to evaluate the contribution of non-neuronal TRPV1 to the up-regulation of the pTRPV1/TRPV1 ratio observed in AS-TIIP rats, we gave resiniferatoxin (RTX) to several groups of rats to destroy TRPV1 containing nerve fibers and subsequently examined the changes in the ratio of TRPV1 and pTRPV1 expression in paw lysates from sham (pH 7.0 and 4.0) and TIIP (pH 7.0 and 4.0) rats. Although TRPV1 was still present in hind paw lysates from RTX treated rats, there were no significant changes in the ratio of pTRPV1/TRPV1 in AS-TIIP rats (Figure 4D). These results indicated that TRPV1 receptors associated with keratinocytes or other non-neuronal sources did not contribute to the increase in pTRPV1/TRPV1 ratios that we observed in AS-TIIP animals. Collectively, these findings suggest that the transitional rate of PKC dependent phosphorylation of TRPV1 in peripheral nerve fibers is an important factor in the development of heat hypersensitivity in chronic ischemic conditions.
P2Y1 receptors are Gq-coupled receptors located in sensory neurons and these receptors have been implicated in sensory transduction [30, 51, 52]. There are several reports suggesting that there is a potential relationship between the P2Y1 and TRPV1 receptors that contributes to increased pain hypersensitivity [7, 30, 53–55]. P2Y1 receptors are located primarily in small diameter sensory neurons, and thus it is perhaps not surprising that over 80% of CGRP neuronal profiles in DRGs contain P2Y1 receptors . Interestingly Gerevich et al. demonstrated that P2X3, TRPV1, and P2Y1 receptors were co-expressed in ~80% of small diameter DRG cells . Furthermore, there was direct evidence supporting a functional relationship between P2Y1 and TRPV1 in DRG neurons; thus, Yousuf et al. demonstrated that ADP-induced activation of P2Y1 receptors facilitated capsaicin-induced currents, and this facilitatory effect was prevented by protein kinase C inhibition . On the other hand, the relationship and interaction between P2Y1 and TRPV1 receptors have not yet been examined in vivo. In the current study, we examined the potential interaction between P2Y1 and TRPV1 receptors and demonstrated that this interaction resulted in the development of a TH response in ischemic rats. As indicated in Figure 7, we found that the creation of a more acidic environment in the ischemic hind paw resulted in the up-regulation of PKC-dependent pTRPV1 expression. Moreover, pre-injection of the P2Y1 receptor antagonist, MRS2179 significantly reduced this increase in pTRPV1 expression. Based on these results, we conclude that activation of P2Y1 receptors in an acidic environment modulates TRPV1 activity (i.e. phosphorylation at the S800 site) and ultimately causes the development of TH under peripheral ischemic conditions. Although we do not delineate the downstream individual molecular steps resulting from activation of P2Y1 receptors in this study, it is feasible to consider that activation of P2Y1 receptors can directly phosphorylate TRPV1 through Gq/G11 related intracellular cascades. When agonists stimulate this type of receptor, phosphatidylinositide-specific phospholipase C (PLC) is activated and subsequently causes hydrolysis of PIP2 in the plasma membrane. Inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG) are generated by PIP2 hydrolysis resulting in the release of Ca2+ from intracellular stores and subsequent activation of the protein kinase C (PKC) pathway [56–58].
One of the questions resulting from the current study relates to explaining the mechanism by which acidic tissue conditions such as that associated with ischemia affects P2Y1Rs. One possibility is that the lower pH found in ischemic tissue changes the agonist affinity of the P2Y1 receptor. Many reports have demonstrated that extracellular protonation modulates the affinity of the ATP binding site and enhances the agonist potency of P2 receptors. For example, Li et al. demonstrated that extracellular protons regulated the function of P2X receptors by modulating the affinity of the ATP binding site . Furthermore, extracellular protons have been shown to significantly potentiate the agonist potency of recombinant P2Y4 receptors, indicating the functional potentiation of P2Y receptors by protons . Furthermore, we should also consider the possibility that the concentration of P2Y receptor agonists at the tissue site might be changed by lower tissue pH. In this regard, Dulla et al. reported that ATP hydrolysis to ADP and adenosine (by ecto-nucleotidases) was closely link to the PCO2 level and pH in hippocampal slices, and changes in nucleotides levels ultimately modulated neuronal excitability in the forebrain . In addition, Sowa et al. demonstrated that prostatic acid phosphatase (PAP), which was expressed in nociceptive neurons and functions as an ectonucleotidase, had pH-dependent ectonucleotidase activity. At neutral pH, mPAP primarily dephosphorylated AMP; however, under acidic extracellular conditions, mPAP could dephosphorylate all purine nucleotides (AMP, ADP, ATP) . Collectively, these reports suggest that the acidic condition of the tissue can change nucleotidase activity leading to increased dephosphorylation of ATP, which would result in an increase in ADP concentration and increased activatation of P2Y1 receptors.
In conclusion, the present study clearly demonstrates that the presence of chronic ischemia in combination with increased tissue acidity can alter TRPV1 receptor sensitivity, not by a direct action of protons on the TRPV1 receptor, but rather by an indirect action of ATP on TRPV1 receptors that is mediated via a Gq-coupled P2Y1 receptor. Furthermore, this activation of P2Y1 receptors by an increase acidic tissue environment results in a PKC-dependent TRPV1 phosphorylation, which ultimately contributes to the development of thermal hyperalgesia. Thus, this study suggests a novel peripheral mechanism that may underlie the development of thermal hyperalgesia in chronic ischemic patients with severe acidosis.
This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST) (2012–0005436 and 2012R1A3A2048834).
- Huang J, Zhang X, McNaughton PA: Inflammatory pain: the cellular basis of heat hyperalgesia. Curr Neuropharmacol 2006, 4: 197–206. 10.2174/157015906778019554PubMed CentralPubMedView ArticleGoogle Scholar
- Cavanaugh DJ, Lee H, Lo L, Shields SD, Zylka MJ, Basbaum AI, Anderson DJ: Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli. Proc Natl Acad Sci USA 2009, 106: 9075–9080. 10.1073/pnas.0901507106PubMed CentralPubMedView ArticleGoogle Scholar
- Wood JN, Eijkelkamp N: Noxious mechanosensation - molecules and circuits. Curr Opin Pharmacol 2012, 12: 4–8. 10.1016/j.coph.2011.10.013PubMedView ArticleGoogle Scholar
- Wood JN, Heath MJ: Molecules that specify modality: mechanisms of nociception. J Pain 2000, 1: 19–25. 10.1054/jpai.2000.9807aPubMedView ArticleGoogle Scholar
- Planells-Cases R, Garcia-Sanz N, Morenilla-Palao C, Ferrer-Montiel A: Functional aspects and mechanisms of TRPV1 involvement in neurogenic inflammation that leads to thermal hyperalgesia. Pflugers Arch 2005, 451: 151–159. 10.1007/s00424-005-1423-5PubMedView ArticleGoogle Scholar
- Holzer P: The pharmacological challenge to tame the transient receptor potential vanilloid 1 (TRPV1) nocisensor. Br J Pharmacol 2008, 155: 1145–1162. 10.1038/bjp.2008.351PubMed CentralPubMedView ArticleGoogle Scholar
- Tominaga M, Wada M, Masu M: Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci USA 2001, 98: 6951–6956. 10.1073/pnas.111025298PubMed CentralPubMedView ArticleGoogle Scholar
- Birdsong WT, Fierro L, Williams FG, Spelta V, Naves LA, Knowles M, Marsh-Haffner J, Adelman JP, Almers W, Elde RP: Sensing muscle ischemia: coincident detection of acid and ATP via interplay of two ion channels. Neuron 2010, 68: 739–749. 10.1016/j.neuron.2010.09.029PubMed CentralPubMedView ArticleGoogle Scholar
- Meru AV, Mittra S, Thyagarajan B, Chugh A: Intermittent claudication: an overview. Atherosclerosis 2006, 187: 221–237. 10.1016/j.atherosclerosis.2005.11.027PubMedView ArticleGoogle Scholar
- Ouriel K: Peripheral arterial disease. Lancet 2001, 358: 1257–1264. 10.1016/S0140-6736(01)06351-6PubMedView ArticleGoogle Scholar
- Lang PM, Schober GM, Rolke R, Wagner S, Hilge R, Offenbacher M, Treede RD, Hoffmann U, Irnich D: Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease. Pain 2006, 124: 190–200. 10.1016/j.pain.2006.04.011PubMedView ArticleGoogle Scholar
- McDermott MM, Greenland P, Liu K, Guralnik JM, Criqui MH, Dolan NC, Chan C, Celic L, Pearce WH, Schneider JR: Leg symptoms in peripheral arterial disease. JAMA 2001, 286: 1599–1606. 10.1001/jama.286.13.1599PubMedView ArticleGoogle Scholar
- Seo HS, Kim HW, Roh DH, Yoon SY, Kwon YB, Han HJ, JIN MC, Beitz AJ, Lee JH: A new rat model for thrombus-induced ischemic pain (TIIP); development of bilateral mechanical allodynia. Pain 2008, 139: 520–532. 10.1016/j.pain.2008.06.011PubMedView ArticleGoogle Scholar
- Seo HS, Roh DH, Yoon SY, Kang SY, Moon JY, Kim HW, Han HJ, Chung JM, Beitz AJ, Lee JH: Peripheral acid-sensing Ion channels and P2X receptors contribute to mechanical allodynia in a rodent thrombus-induced ischemic pain model. J Pain 2010, 11: 718–727. 10.1016/j.jpain.2009.10.010PubMedView ArticleGoogle Scholar
- Pan HL, Chen SR: Sensing tissue ischemia: another New function for capsaicin receptors? Circulation 2004, 110: 1826–1831. 10.1161/01.CIR.0000142618.20278.7APubMedView ArticleGoogle Scholar
- Premkumar LS, Bishnoi M: Disease-related changes in TRPV1 expression and its implications for drug development. Curr Top Med Chem 2011, 11: 2192–2209. 10.2174/156802611796904834PubMedView ArticleGoogle Scholar
- Takemura M, Quarcoo D, Niimi A, Dinh Q, Geppetti P, Fischer A, Chung KF, Groneberg DA: Is TRPV1 a useful target in respiratory diseases? Pulm Pharmacol Ther 2008, 21: 833–839. 10.1016/j.pupt.2008.09.005PubMedView ArticleGoogle Scholar
- Xing J, Gao Z, Lu J, Sinoway LI, Li J: Femoral artery occlusion augments TRPV1-mediated sympathetic responsiveness. Am J Physiol Heart Circ Physiol 2008, 295: H1262-H1269. 10.1152/ajpheart.00271.2008PubMed CentralPubMedView ArticleGoogle Scholar
- Zahner MR, Li DP, Chen SR, Pan HL: Cardiac vanilloid receptor 1‒expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats. J Physiol 2003, 551: 515–523. 10.1113/jphysiol.2003.048207PubMed CentralPubMedView ArticleGoogle Scholar
- Seo HS, Roh DH, Kwon SG, Yoon SY, Kang SY, Moon JY, Choi SR, Beitz AJ, Lee JH: Acidic pH facilitates peripheral αβmeATP-mediated nociception in rats: Differential roles of P2X, P2Y, ASIC and TRPV1 receptors in ATP-induced mechanical allodynia and thermal hyperalgesia. Neuropharmacology 2010, 60: 580–586.PubMedView ArticleGoogle Scholar
- Sluka KA, Kalra A, Moore SA: Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 2001, 24: 37–46. 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8PubMedView ArticleGoogle Scholar
- Roh DH, Kim HW, Yoon SY, Seo HS, Kwon YB, Han HJ, Beitz AJ, Lee JH: Depletion of capsaicin sensitive afferents prevents lamina‒dependent increases in spinal N‒methyl‒d‒aspartate receptor subunit 1 expression and phosphorylation associated with thermal hyperalgesia in neuropathic rats. Eur J Pain 2008, 12: 552–563. 10.1016/j.ejpain.2007.09.002PubMedView ArticleGoogle Scholar
- Mekhail K, Gunaratnam L, Bonicalzi M-E, Lee S: HIF activation by pH-dependent nucleolar sequestration of VHL. Nat Cell Biol 2004, 6: 642–647. 10.1038/ncb1144PubMedView ArticleGoogle Scholar
- Potter C, Harris AL: Hypoxia inducible carbonic anhydrase IX, marker of tumor hypoxia, survival pathway and therapy target. Cell Cycle 2004, 3: 164–167.PubMedView ArticleGoogle Scholar
- Riley DA, Ellis S, Bain J: Carbonic anhydrase activity in skeletal muscle fiber types, axons, spindles, and capillaries of rat soleus and extensor digitorum longus muscles. J Histochem Cytochem 1982, 30: 1275–1288. 10.1177/30.12.6218195PubMedView ArticleGoogle Scholar
- Svastová E, Hulı́kova A, Rafajova M, Zat’ovicova M, Gibadulinova A, Casini A, Cecchi A, Scozzafava A, Supuran CT, Pastorek J, Pastorekova S: Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 2004, 577: 439–445. 10.1016/j.febslet.2004.10.043PubMedView ArticleGoogle Scholar
- Li X, Alvarez B, Casey JR, Reithmeier RA, Fliegel L: Carbonic anhydrase II binds to and enhances activity of the Na+/H + exchanger. J Biol Chem 2002, 277: 36085–36091. 10.1074/jbc.M111952200PubMedView ArticleGoogle Scholar
- Heyman SN, Rosen S, Rosenberger C: Hypoxia-inducible factors and the prevention of acute organ injury. Crit Care 2011, 15: 209. 10.1186/cc9991PubMed CentralPubMedView ArticleGoogle Scholar
- Ho TK, Rajkumar V, Ponticos M, Leoni P, Black DCM, Abraham DJ, Baker DM: Increased endogenous angiogenic response and hypoxia-inducible factor-1α in human critical limb ischemia. J Vasc Surg 2006, 43: 125–133. 10.1016/j.jvs.2005.08.042PubMedView ArticleGoogle Scholar
- Dussor G, Koerber HR, Oaklander AL, Rice FL, Molliver DC: Nucleotide signaling and cutaneous mechanisms of pain transduction. Brain Res Rev 2009, 60: 24–35. 10.1016/j.brainresrev.2008.12.013PubMed CentralPubMedView ArticleGoogle Scholar
- Gopinath P, Wan E, Holdcroft A, Facer P, Davis JB, Smith GD, Bountra C, Anand P: Increased capsaicin receptor TRPV1 in skin nerve fibres and related vanilloid receptors TRPV3 and TRPV4 in keratinocytes in human breast pain. BMC Womens Health 2005, 5: 2. 10.1186/1472-6874-5-2PubMed CentralPubMedView ArticleGoogle Scholar
- Li WH, Lee YM, Kim JY, Kang S, Kim S, Kim KH, Park CH, Chung JH: Transient receptor potential vanilloid-1 mediates heat-shock-induced matrix metalloproteinase-1 expression in human epidermal keratinocytes. J Invest Dermatol 2007, 127: 2328–2335. 10.1038/sj.jid.5700880PubMedView ArticleGoogle Scholar
- Mandadi S, Sokabe T, Shibasaki K, Katanosaka K, Mizuno A, Moqrich A, Patapoutian A, Fukumi-Tominaga T, Mizumura K, Tominaga M: TRPV3 in keratinocytes transmits temperature information to sensory neurons via ATP. Pflugers Arch 2009, 458: 1093–1102. 10.1007/s00424-009-0703-xPubMed CentralPubMedView ArticleGoogle Scholar
- Siesjö BK: Acidosis and ischemic brain damage. Neurochem Pathol 1988, 9: 31–88.PubMedGoogle Scholar
- Li PA, Siesjö B: Role of hyperglycaemia‒related acidosis in ischaemic brain damage. Acta Physiol Scand 1997, 161: 567–580. 10.1046/j.1365-201X.1997.00264.xPubMedView ArticleGoogle Scholar
- Naves LA, McCleskey EW: An acid-sensing ion channel that detects ischemic pain. Braz J Med Biol Res 2005, 38: 1561–1569.PubMedView ArticleGoogle Scholar
- Steen KH, Steen AE, Kreysel HW, Reeh PW: Inflammatory mediators potentiate pain induced by experimental tissue acidosis. Pain 1996, 66: 163–170. 10.1016/0304-3959(96)03034-5PubMedView ArticleGoogle Scholar
- Steen KH, Steen AE, Reeh PW: A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro. J Neurosci 1995, 15: 3982–3989.PubMedGoogle Scholar
- Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, Di Virgilio F: Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 2008, 3: 2599. 10.1371/journal.pone.0002599View ArticleGoogle Scholar
- Dell’Antonio G, Quattrini A, Cin ED, Fulgenzi A, Ferrero ME: Relief of inflammatory pain in rats by local use of the selective P2X7 ATP receptor inhibitor, oxidized ATP. Arthritis Rheum 2002, 46: 3378–3385. 10.1002/art.10678PubMedView ArticleGoogle Scholar
- Ikeuchi M, Kolker SJ, Burnes LA, Walder RY, Sluka KA: Role of ASIC3 in the primary and secondary hyperalgesia produced by joint inflammation in mice. Pain 2008, 137: 662–669. 10.1016/j.pain.2008.01.020PubMed CentralPubMedView ArticleGoogle Scholar
- Walder RY, Rasmussen LA, Rainier JD, Light AR, Wemmie JA, Sluka KA: ASIC1 and ASIC3 play different roles in the development of Hyperalgesia after inflammatory muscle injury. J Pain 2010, 11: 210–218. 10.1016/j.jpain.2009.07.004PubMed CentralPubMedView ArticleGoogle Scholar
- Hamamoto DT, Ortiz-Gonzalez XR, Honda JM, Kajander KC: Intraplantar injection of hyaluronic acid at low pH into the rat hindpaw produces tissue acidosis and enhances withdrawal responses to mechanical stimuli. Pain 1998, 74: 225–234. 10.1016/S0304-3959(97)00185-1PubMedView ArticleGoogle Scholar
- Aneiros E, Cao L, Papakosta M, Stevens EB, Phillips S, Grimm C: The biophysical and molecular basis of TRPV1 proton gating. EMBO J 2011, 30: 994–1002. 10.1038/emboj.2011.19PubMed CentralPubMedView ArticleGoogle Scholar
- Gavva NR: AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties. J Pharmacol Exp Ther 2004, 313: 474–484. 10.1124/jpet.104.079855PubMedView ArticleGoogle Scholar
- Neelands TR, Jarvis MF, Han P, Faltynek CR, Surowy CS: Acidification of rat TRPV1 alters the kinetics of capsaicin responses. Mol Pain 2005, 1: 28. 10.1186/1744-8069-1-28PubMed CentralPubMedView ArticleGoogle Scholar
- Wang Y: The functional regulation of TRPV1 and its role in pain sensitization. Neurochem Res 2008, 33: 2008–2012. 10.1007/s11064-008-9750-5PubMedView ArticleGoogle Scholar
- Ma W, Quirion R: Inflammatory mediators modulating the transient receptor potential vanilloid 1 receptor: therapeutic targets to treat inflammatory and neuropathic pain. Expert Opin Ther Targets 2007, 11: 307–320. 10.1517/14728184.108.40.2067PubMedView ArticleGoogle Scholar
- Mandadi S, Numazaki M, Tominaga M, Bhat MB, Armati PJ, Roufogalis BD: Activation of protein kinase C reverses capsaicin-induced calcium-dependent desensitization of TRPV1 ion channels. Cell Calcium 2004, 35: 471–478. 10.1016/j.ceca.2003.11.003PubMedView ArticleGoogle Scholar
- Mandadi S, Tominaga T, Numazaki M, Murayama N, Saito N, Armati PJ, Roufogalis BD, Tominaga M: Increased sensitivity of desensitized TRPV1 by PMA occurs through PKC [epsilon]-mediated phosphorylation at S800. Pain 2006, 123: 106–116. 10.1016/j.pain.2006.02.016PubMedView ArticleGoogle Scholar
- Nakamura F, Strittmatter SM: P2Y1 purinergic receptors in sensory neurons: contribution to touch-induced impulse generation. Proc Natl Acad Sci USA 1996, 93: 10465–10470. 10.1073/pnas.93.19.10465PubMed CentralPubMedView ArticleGoogle Scholar
- Malin SA, Molliver DC: Gi-and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior. Mol Pain 2010, 6: 21. 10.1186/1744-8069-6-21PubMed CentralPubMedView ArticleGoogle Scholar
- Ruan HZ, Burnstock G: Localisation of P2Y 1 and P2Y 4 receptors in dorsal root, nodose and trigeminal ganglia of the rat. Histochem Cell Biol 2003, 120: 415–426. 10.1007/s00418-003-0579-3PubMedView ArticleGoogle Scholar
- Gerevich Z, Borvendeg SJ, Schroder W, Franke H, Wirkner K, Norenberg W, Furst S, Gillen C, Illes P: Inhibition of N-type voltage-activated calcium channels in rat dorsal root ganglion neurons by P2Y receptors is a possible mechanism of ADP-induced analgesia. J Neurosci 2004, 24: 797–807. 10.1523/JNEUROSCI.4019-03.2004PubMedView ArticleGoogle Scholar
- Yousuf A, Klinger F, Schicker K, Boehm S: Nucleotides control the excitability of sensory neurons via two P2Y receptors and a bifurcated signaling cascade. Pain 2011, 152: 1899–1908. 10.1016/j.pain.2011.04.016PubMed CentralPubMedView ArticleGoogle Scholar
- Mandadi S, Armati PJ, Roufogalis BD: Protein kinase C modulation of thermo-sensitive transient receptor potential channels: Implications for pain signaling. J Nat Sci Biol Med 2011, 2: 13–25. 10.4103/0976-9668.82311PubMed CentralPubMedView ArticleGoogle Scholar
- Kolen K, Slegers H: Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks. Purinergic Signal 2006, 2: 451–469. 10.1007/s11302-006-9008-0PubMed CentralPubMedView ArticleGoogle Scholar
- Erb L, Liao Z, Seye CI, Weisman GA: P2 receptors: intracellular signaling. Pflugers Arch 2006, 452: 552–562. 10.1007/s00424-006-0069-2PubMedView ArticleGoogle Scholar
- Li C, Peoples RW, Weight FF: Enhancement of ATP-activated current by protons in dorsal root ganglion neurons. Pflugers Arch 1997, 433: 446–454. 10.1007/s004240050299PubMedView ArticleGoogle Scholar
- Wildman SS, Unwin RJ, King BF: Extended pharmacological profiles of rat P2Y2 and rat P2Y4 receptors and their sensitivity to extracellular H + and Zn2+ ions. Br J Pharmacol 2003, 140: 1177–1186. 10.1038/sj.bjp.0705544PubMed CentralPubMedView ArticleGoogle Scholar
- Dulla CG, Dobelis P, Pearson T, Frenguelli BG, Staley KJ, Masino SA: Adenosine and ATP link PCO2 to cortical excitability via pH. Neuron 2005, 48: 1011–1023. 10.1016/j.neuron.2005.11.009PubMed CentralPubMedView ArticleGoogle Scholar
- Sowa NA, Vadakkan KI, Zylka MJ: Recombinant mouse PAP Has pH-dependent ectonucleotidase activity and acts through A1-adenosine receptors to mediate antinociception. PLoS One 2009, 4: 4248. 10.1371/journal.pone.0004248View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.